Loading organizations...
Lee Equity Partners is a private equity firm specializing in financial services and healthcare, applying deep domain expertise and a thematic investment approach. The firm partners with management teams to scale operations, enhance performance, and pursue growth through organic initiatives and strategic acquisitions. This collaborative strategy builds robust, high-performing businesses.
Thomas H. Lee founded Lee Equity in 2006, establishing the firm on principles of long-term alignment, close partnership, and a dedicated drive for business success. Lee, a seasoned investor, leveraged investment acumen and intellectual rigor within specific sectors to foster enduring value creation.
The firm partners with founders, entrepreneurs, and management teams seeking to expand and optimize their enterprises. Lee Equity’s vision is to be a preferred partner, actively supporting companies to strengthen infrastructure, improve governance, and strategically drive growth. It aims to deliver lasting value through specialized sector knowledge and hands-on operational engagement.
Key people at Lee Equity.
Lee Equity was founded in 2006 by Thomas H. Lee (Founder ,Chairman and CEO).
Lee Equity was founded in 2006 by Thomas H. Lee (Founder ,Chairman and CEO).
Key people at Lee Equity.
Lee Equity has 1 tracked investment across 1 company. The latest tracked deal is $145.0M Series B in Zhaoke Ophthalmology Pharmaceutical in October 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 9, 2020 | Zhaoke Ophthalmology Pharmaceutical | $145.0M Series B | Hillhouse Capital, Loyal Valley Capital, TPG | Coyote Ventures, OrbiMed |